New Strategies in Treating Respiratory Failure: NIV and HFNO as 
complementary therapy 

 

Speaker:

Nicholas S. Hill, MD

Chief, Pulmonary & Critical Care and Sleep Division Pulmonary, 

Critical Care and Sleep Division
Tufts Medical Center

Boston, MA

 

Description: 

Noninvasive ventilation (NIV) or the delivery of positive pressure ventilation delivered through a noninvasive interface has become more common as its benefits are increasingly recognized. NIV has proven efficacy for hypercapnic respiratory failure, especially that due to COPD exacerbations. High-flow nasal cannula (HFNO) comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. HFNO has shown promise to treat hypoxic respiratory failure. This webinar will explore a new strategy in the treatment of respiratory conditions. Specifically, this presentation will discuss how HFNO may play a useful complementary role during breaks from NIV.

 

Learning Objectives:

Upon completion of this activity, the participant will be able to:

Discuss indications for NIV and HFNO

Compare and contrast physiologic actions of NIV and HFNO

Demonstrate how HFNO and NIV can work in complementary fashion

 

Bio:

Nicholas S Hill, MD, is Professor of Medicine at Tufts University School of Medicine, and Chief of the Pulmonary & Critical Care and Sleep Division at Tufts Medical Center in Boston, MA. His primary research interests include the role of angiogenic factors in pulmonary vascular biology, therapeutic approaches for clinical pulmonary hypertension, and evaluating ways of delivering and testing the efficacy of noninvasive ventilation. Dr Hill has authored or coauthored more than 200 articles in peer-reviewed journals such as American Journal of Physiology, Respiratory Medicine, and Critical Care Medicine. He is a member of the American College of Chest Physicians, American Thoracic Society (also past president), American Association for the Advancement of Science, and Pulmonary Hypertension Association.

Supported by an educational grant 
from

Philips Healthcare

Continuing Education for Nurses and Respiratory Therapists

This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477  and the
Florida Board of Nursing Provider # 50-17032

This program has been approved for 1.0 Non-Traditional contact hours Continuing Respiratory Care Education (CRCE) credit by the
American Association for Respiratory Care, 9425 N. MacArthur Blvd., Suite 100, Irving TX 75063